Skip to search.
 STI Down 1.83%

Becton, Dickinson and Company (BDX)

-NYSE
134.34 Up 1.46(1.10%) 10 Feb 05:01 SGT
|After Hours : 132.47 Down 1.87 (1.39%) 10 Feb 06:21 SGT
Prev Close:132.88
Open:129.58
Bid:127.46 x 100
Ask:141.32 x 100
1y Target Est:164.97
Beta:1.12081
Earnings Date:5 May - 9 May (Est.)
Day's Range:129.50 - 135.38
52wk Range:128.87 - 157.50
Volume:1,701,011
Avg Vol (3m):1,181,530
Market Cap:28.46B
P/E (ttm):41.46
EPS (ttm):3.24
Div & Yield:2.64 (1.95%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BDXUp 1.10%28.46B
BAXUp 0.53%19.80B
ABTDown 1.23%55.19B

Key Statistics

Forward P/E (1 yr):14.34
P/S (ttm):2.51
Ex-Dividend Date:08-Mar-16

Analysts

Annual EPS Est (Sep-16) :8.41
Quarterly EPS Est (Mar-16) :2.02
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company’s BD Medical segment offers syringes and pen needles for diabetes; needles, syringes, and intravenous cat... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback